When Congress passed landmark Medicare reforms last year, critics opposed a provision banning Americans from buying "Canadian" prescription drugs and a study of the safety and cost benefits of cross border purchasing was mandated in the legislation. For several years, healthcare policy analysts and health safety experts have produced a cacophony of powerful objections to importation based on worries about safety and pricing. Now adding to the din of serious concern comes this study from the Department of Health and Human Services produced by a respected, international expert panel that not only highlights the dangers of importation, but is likely...